CN111537647A - Ultra-high performance liquid chromatography analysis method for crimson-cleft-camaldine in flos farfarae - Google Patents
Ultra-high performance liquid chromatography analysis method for crimson-cleft-camaldine in flos farfarae Download PDFInfo
- Publication number
- CN111537647A CN111537647A CN202010472520.8A CN202010472520A CN111537647A CN 111537647 A CN111537647 A CN 111537647A CN 202010472520 A CN202010472520 A CN 202010472520A CN 111537647 A CN111537647 A CN 111537647A
- Authority
- CN
- China
- Prior art keywords
- ultra
- performance liquid
- methanol
- high performance
- column
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000001195 ultra high performance liquid chromatography Methods 0.000 title claims description 8
- 238000004458 analytical method Methods 0.000 title claims description 6
- 241000628997 Flos Species 0.000 title claims 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims abstract description 60
- 238000000034 method Methods 0.000 claims abstract description 26
- 238000002414 normal-phase solid-phase extraction Methods 0.000 claims abstract description 20
- 239000007788 liquid Substances 0.000 claims abstract description 17
- 239000000243 solution Substances 0.000 claims abstract description 13
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims abstract description 12
- 238000001514 detection method Methods 0.000 claims abstract description 12
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000013558 reference substance Substances 0.000 claims abstract description 10
- 238000004704 ultra performance liquid chromatography Methods 0.000 claims abstract description 9
- 239000007864 aqueous solution Substances 0.000 claims abstract description 8
- 239000012071 phase Substances 0.000 claims abstract description 7
- 239000002904 solvent Substances 0.000 claims abstract description 7
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims abstract description 5
- 239000000706 filtrate Substances 0.000 claims abstract description 4
- 235000004869 Tussilago farfara Nutrition 0.000 claims description 22
- 239000002585 base Substances 0.000 claims description 14
- 239000012085 test solution Substances 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 8
- 239000012088 reference solution Substances 0.000 claims description 7
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 6
- 239000012488 sample solution Substances 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- FWFGVMYFCODZRD-UHFFFAOYSA-N oxidanium;hydrogen sulfate Chemical compound O.OS(O)(=O)=O FWFGVMYFCODZRD-UHFFFAOYSA-N 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 239000000523 sample Substances 0.000 claims description 4
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 3
- 239000003513 alkali Substances 0.000 claims description 3
- GHQPBDDZGPAVJP-UHFFFAOYSA-N azanium;methanol;hydroxide Chemical compound N.O.OC GHQPBDDZGPAVJP-UHFFFAOYSA-N 0.000 claims description 3
- 235000019253 formic acid Nutrition 0.000 claims description 3
- 239000002245 particle Substances 0.000 claims description 3
- 240000000377 Tussilago farfara Species 0.000 claims description 2
- 230000003213 activating effect Effects 0.000 claims description 2
- 239000012535 impurity Substances 0.000 claims description 2
- 239000012528 membrane Substances 0.000 claims description 2
- 238000009210 therapy by ultrasound Methods 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims 3
- 238000005303 weighing Methods 0.000 claims 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- 150000001768 cations Chemical class 0.000 claims 1
- 239000003480 eluent Substances 0.000 claims 1
- 238000002386 leaching Methods 0.000 claims 1
- 238000002156 mixing Methods 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- 238000005406 washing Methods 0.000 claims 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 11
- 238000004587 chromatography analysis Methods 0.000 abstract description 8
- 238000004949 mass spectrometry Methods 0.000 abstract description 4
- 238000002347 injection Methods 0.000 abstract description 3
- 239000007924 injection Substances 0.000 abstract description 3
- 208000002260 Keloid Diseases 0.000 abstract description 2
- 210000001117 keloid Anatomy 0.000 abstract description 2
- 241000249864 Tussilago Species 0.000 description 20
- 229930002356 pyrrolizidine alkaloid Natural products 0.000 description 13
- 238000012360 testing method Methods 0.000 description 11
- 206010011224 Cough Diseases 0.000 description 7
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 7
- 239000006187 pill Substances 0.000 description 7
- ADRDEXBBJTUCND-UHFFFAOYSA-N pyrrolizidine Chemical class C1CCN2CCCC21 ADRDEXBBJTUCND-UHFFFAOYSA-N 0.000 description 6
- 238000010828 elution Methods 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 230000002440 hepatic effect Effects 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 241000218158 Clematis Species 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 229930013930 alkaloid Natural products 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000004190 ion pair chromatography Methods 0.000 description 3
- MWUXSHHQAYIFBG-UHFFFAOYSA-N nitrogen oxide Inorganic materials O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 3
- QWSZRRAAFHGKCH-UHFFFAOYSA-M sodium;hexane-1-sulfonate Chemical compound [Na+].CCCCCCS([O-])(=O)=O QWSZRRAAFHGKCH-UHFFFAOYSA-M 0.000 description 3
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 2
- 241000208838 Asteraceae Species 0.000 description 2
- 238000008050 Total Bilirubin Reagent Methods 0.000 description 2
- 238000010811 Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry Methods 0.000 description 2
- 208000012634 Venoocclusive liver disease Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- 238000005341 cation exchange Methods 0.000 description 2
- 239000003729 cation exchange resin Substances 0.000 description 2
- 125000002091 cationic group Chemical group 0.000 description 2
- 208000019425 cirrhosis of liver Diseases 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 208000018645 hepatic veno-occlusive disease Diseases 0.000 description 2
- 210000003494 hepatocyte Anatomy 0.000 description 2
- 231100000334 hepatotoxic Toxicity 0.000 description 2
- 230000003082 hepatotoxic effect Effects 0.000 description 2
- 231100000304 hepatotoxicity Toxicity 0.000 description 2
- FYAQQULBLMNGAH-UHFFFAOYSA-N hexane-1-sulfonic acid Chemical compound CCCCCCS(O)(=O)=O FYAQQULBLMNGAH-UHFFFAOYSA-N 0.000 description 2
- 238000004189 ion pair high performance liquid chromatography Methods 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000007056 liver toxicity Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000004007 reversed phase HPLC Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- 241000332371 Abutilon x hybridum Species 0.000 description 1
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 1
- 108010082126 Alanine transaminase Proteins 0.000 description 1
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 1
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 1
- APSNPMVGBGZYAJ-LYRQQEFTSA-N Clematin Natural products O(C[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](Oc2cc(O)c3C(=O)C[C@@H](c4cc(OC)c(O)cc4)Oc3c2)O1)[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](C)O1 APSNPMVGBGZYAJ-LYRQQEFTSA-N 0.000 description 1
- 102000002004 Cytochrome P-450 Enzyme System Human genes 0.000 description 1
- 108010015742 Cytochrome P-450 Enzyme System Proteins 0.000 description 1
- 206010064571 Gene mutation Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010019837 Hepatocellular injury Diseases 0.000 description 1
- 101000610640 Homo sapiens U4/U6 small nuclear ribonucleoprotein Prp3 Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 241000218922 Magnoliophyta Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 150000001204 N-oxides Chemical class 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical group C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 1
- 101001110823 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) 60S ribosomal protein L6-A Proteins 0.000 description 1
- 101000712176 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) 60S ribosomal protein L6-B Proteins 0.000 description 1
- HPDHKHMHQGCNPE-QLJRNOHWSA-N Senkirkine Chemical compound O1C(=O)C(=C/C)\C[C@@H](C)[C@@](C)(O)C(=O)OC\C2=C\CN(C)CC[C@@H]1C2=O HPDHKHMHQGCNPE-QLJRNOHWSA-N 0.000 description 1
- HPDHKHMHQGCNPE-FQWLTQODSA-N Senkirkine Natural products O=C1/C(=C/C)/C[C@H](C)[C@](O)(C)C(=O)OCC=2C(=O)[C@H](O1)CCN(C)CC=2 HPDHKHMHQGCNPE-FQWLTQODSA-N 0.000 description 1
- 240000002299 Symphytum officinale Species 0.000 description 1
- 235000005865 Symphytum officinale Nutrition 0.000 description 1
- 102100040374 U4/U6 small nuclear ribonucleoprotein Prp3 Human genes 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 208000023819 chronic asthma Diseases 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 1
- HPDHKHMHQGCNPE-UHFFFAOYSA-N crotaverrine Natural products O1C(=O)C(=CC)CC(C)C(C)(O)C(=O)OCC2=CCN(C)CCC1C2=O HPDHKHMHQGCNPE-UHFFFAOYSA-N 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 238000010812 external standard method Methods 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- ICYOLCFDSJJLAC-UHFFFAOYSA-N gramine Chemical compound C1=CC=C[C]2C(CN(C)C)=CN=C21 ICYOLCFDSJJLAC-UHFFFAOYSA-N 0.000 description 1
- GOERTRUXQHDLHC-UHFFFAOYSA-N gramine Natural products COC1=CC=C2NC=C(CN(C)C)C2=C1 GOERTRUXQHDLHC-UHFFFAOYSA-N 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 208000037805 labour Diseases 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 231100000849 liver cell damage Toxicity 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 235000009048 phenolic acids Nutrition 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 238000005173 quadrupole mass spectroscopy Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000041 toxicology testing Toxicity 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 238000002211 ultraviolet spectrum Methods 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/86—Signal analysis
- G01N30/8675—Evaluation, i.e. decoding of the signal into analytical information
- G01N30/8679—Target compound analysis, i.e. whereby a limited number of peaks is analysed
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
- G01N2030/062—Preparation extracting sample from raw material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
- G01N2030/065—Preparation using different phases to separate parts of sample
Landscapes
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Library & Information Science (AREA)
- Engineering & Computer Science (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Abstract
本发明涉及一种款冬花中克氏千里光碱的超高效液相色谱分析方法,包括以下步骤:取克氏千里光碱对照品,加甲醇制成每1ml含20μg的溶液;取款冬花粉末,加甲醇,超声处理,过滤,残渣用甲醇洗涤,过滤,合并滤液,减压回收溶剂,加入0.5%的硫酸水溶液溶解或混悬,进行固相萃取;色谱条件:流动相为乙腈‑0.1%磷酸水溶液=15:85;流速0.3ml/min;色谱柱:UPLC柱,紫外检测器,检测波长220nm;柱温:30℃;进样量:1μl;精密吸取对照品溶液和供试品溶液各1μl,注入超高效液相色谱仪。该方法无需与质谱连用,无需添加离子对试剂,5min内即可完成对克氏千里光碱的检测,灵敏度高(定量限为0.1μg·ml‑1),准确性和重现性好,检测成本低。The invention relates to an ultra-high performance liquid chromatographic analysis method for senilin in coltsfootia, comprising the following steps: taking a reference substance of senilin, adding methanol to prepare a solution containing 20 μg per 1 ml; , add methanol, sonicate, filter, wash the residue with methanol, filter, combine the filtrates, recover the solvent under reduced pressure, add 0.5% aqueous sulfuric acid to dissolve or suspend, and perform solid phase extraction; chromatography conditions: mobile phase is acetonitrile-0.1% Phosphoric acid aqueous solution=15:85; flow rate 0.3ml/min; chromatographic column: UPLC column, UV detector, detection wavelength 220nm; column temperature: 30℃; injection volume: 1μl; 1 μl was injected into the ultra-high performance liquid chromatograph. The method does not need to be used in conjunction with mass spectrometry and does not need to add ion - pairing reagents, and can complete the detection of keloids within 5 minutes. low cost.
Description
技术领域technical field
本发明涉及款冬花质量标准检测方法,具体涉及一种款冬花中克氏千里光碱的超高效液相色谱分析方法。The invention relates to a method for detecting quality standards of coltsfoot, in particular to an ultra-high performance liquid chromatography analysis method for senilin in coltsfoot.
背景技术Background technique
款冬花为菊科植物款冬(Tussilago farfara L.)的干燥花蕾,始载于《神农本草经》,列为中品,现收载于在《中国药典》2015年版一部,具有润肺下气,止咳化痰之功效,用于新久咳嗽,喘咳痰多,劳嗽咳血。款冬花是常用中药材,为“古今方用温肺治嗽之最”。《中国药典》2015年版一部收载的以款冬花为组方药材的有二母安嗽丸、川贝雪梨膏、止咳橘红口服液、止咳橘红丸、止嗽化痰丸、咳喘顺丸、桔梗冬花片、润肺止嗽丸、清肺化痰丸、橘红丸、橘红片、橘红胶囊、橘红颗粒,还有儿科常用制剂小儿肺咳颗粒等14种中成药。Coltsfoot is the dried flower buds of the Compositae (Tussilago farfara L.), which was first recorded in the "Shen Nong's Herbal Classic" and is listed as a middle grade. , The effect of relieving cough and resolving phlegm is used for chronic cough, asthma and phlegm, labor cough and hemoptysis. Coltsfoot is a commonly used Chinese herbal medicine, which is "the most ancient and modern prescription for warming the lungs to treat cough". The 2015 edition of "Chinese Pharmacopoeia" contains Ermu Ansou Pills, Chuanbei Xue Li ointment, Cough Juhong Oral Liquid, Cough Juhong Pills, Cough Relieving and Phlegm Pills, Kechuan Shun Pills 14 kinds of Chinese patent medicines, such as bellflower winter flower tablets, lung-running and coughing pills, lung-clearing and phlegm-clearing pills, orange-red pills, orange-red tablets, orange-red capsules, orange-red granules, as well as children's lung cough granules, which are commonly used in pediatrics.
款冬花分布广泛,主产于我国东北、华北、华东、西北和湖北、湖南、江西、贵州、云南、西藏等地,常生于山谷湿地或林下。印度、伊朗、巴基斯坦、俄罗斯、西欧和北非也有分布。款冬花的化学成分复杂,主要含有黄酮、萜类、酚酸、生物碱等多种化合物,具有化痰止咳、降脂、抗炎、抗肿瘤、抗过敏、抗氧化及提高免疫力等多种作用。除有效成分外,款冬花中含有较高含量的吡咯里西啶生物碱类(Pyrrolizidine Alkaloids,PAs),该类成分具有较强的肝毒性,但现行的质量标准中均没有对该类成分的限量控制和风险提示,长期服用该药材,存在较大的用药安全风险。Coltsfoot is widely distributed, mainly produced in Northeast my country, North China, East China, Northwest China and Hubei, Hunan, Jiangxi, Guizhou, Yunnan, Tibet and other places, often born in valley wetlands or under forest. There are also distributions in India, Iran, Pakistan, Russia, Western Europe and North Africa. The chemical composition of coltsfoot is complex, mainly containing various compounds such as flavonoids, terpenes, phenolic acids, alkaloids, etc. effect. In addition to active ingredients, coltsfoot flowers contain high content of pyrrolizidine alkaloids (PAs), which have strong liver toxicity, but there are no such ingredients in the current quality standards. Limitation control and risk reminder, long-term use of this medicinal material, there is a greater risk of drug safety.
吡咯里西啶生物碱(Pyrrolizidine alkaloid,PA)广泛存在于多种植物中,据统计,世界上约有3%的有花植物即6000余种植物含有PAs。迄今为止,PAs已在13个科的植物中检出,多数属于紫草科、菊科千里光族和豆科。毒理学研究表明,在吡咯啶环的1,2位为双键的PAs具有肝脏毒性,称为肝毒性吡咯里西啶生物碱(Hepatotoxic PyrrolizidineAlkaloid,HPA)。HPA可引起不可逆的肝细胞损伤,并导致肝窦阻塞综合征(HepaticSinusoidal Obstruction Syndrome,HSOS)、肝巨细胞症、肝纤维化和肝硬化等不良后果,严重者可导致死亡。HPA进入肝脏,经细胞色素P450氧化代谢后形成脱氢吡咯里西啶生物碱(Dehydropyrrolizidine Alkaloid,DHPA),DHPA代谢后形成二级代谢产物具有很强的亲电能力,可与DNA络合形成DHPA-DNA络合物,DHPA-DNA络合物的形成具有细胞类型特异性,主要在肝窦内皮细胞而不是肝实质细胞中形成,DHPA-DNA形成后难以逆转,在体内蓄积,服用一定量后导致肝窦阻塞综合征(HSOS),且DHPA-DNA络合物可导致多种基因突变,进而诱发肝癌形成。Pyrrolizidine alkaloids (PA) widely exist in a variety of plants. According to statistics, about 3% of the flowering plants in the world, that is, more than 6,000 species of plants contain PAs. So far, PAs have been detected in 13 families of plants, most of which belong to the comfrey family, the Asteraceae family, and the legume family. Toxicological studies have shown that PAs with double bonds at the 1 and 2 positions of the pyrrolidine ring have liver toxicity and are called hepatotoxic pyrrolizidine alkaloids (HPA). HPA can cause irreversible liver cell damage and lead to adverse consequences such as Hepatic Sinusoidal Obstruction Syndrome (HSOS), giant cell disease, liver fibrosis and cirrhosis, and even death in severe cases. HPA enters the liver and is oxidized and metabolized by cytochrome P450 to form dehydropyrrolizidine alkaloid (DHPA). -DNA complexes, the formation of DHPA-DNA complexes is cell type specific, mainly formed in hepatic sinusoidal endothelial cells rather than liver parenchyma cells, DHPA-DNA is difficult to reverse after formation, and accumulates in the body, after taking a certain amount Lead to hepatic sinusoidal obstruction syndrome (HSOS), and DHPA-DNA complex can lead to a variety of gene mutations, and then induce the formation of liver cancer.
1976年,澳大利亚科研人员首次从1公斤款冬花中分离得到25毫克(收率0.0025%)的克氏千里光碱(Senkirkine),采用质谱、核磁共振氢谱以及对照品比对的方法鉴定了结构。克氏千里光碱属于奥索千里光裂碱型大环二酯型生物碱,是款冬花中含量最高的HPA,含量一般为0.002~0.010%,即每克药材中含有20~100μg。约有三分之一的批次含量超过《中国药典》2015年版一部中千里光项下对HPA成分阿多尼弗林碱(同为吡咯里西啶生物碱)规定的限度(0.004%)。按《中国药典》规定的每天用量5~10g计算,每天摄入克氏千里光碱100~1000μg。In 1976, Australian researchers isolated 25 mg (yield 0.0025%) of Senkirkine from 1 kg of coltsfoot flower for the first time. The structure was identified by mass spectrometry, hydrogen NMR and comparison of reference substances. . Sennil is a macrocyclic diester type alkaloid of osso clematis, and it is the highest content of HPA in coltsfoot, and the content is generally 0.002-0.010%, that is, each gram of medicinal materials contains 20-100 μg. About one-third of the batches exceeded the limit (0.004%) of the HPA component adonifrin base (also pyrrolizidine alkaloid) under the Qianliguang item in the 2015 edition of the Chinese Pharmacopoeia. . Calculated according to the daily dosage of 5-10g stipulated in the "Chinese Pharmacopoeia", the daily intake of senilin is 100-1000μg.
克式千里光碱是款冬花中最主要的肝毒性成分。将款冬花中提取的克式千里光碱连续7d对小鼠进行腹腔注射,其血清生化指标中的谷丙转氨酶(GOT)、谷草转氨酶(GPT)和总胆红素(TBIL)与对照组相比显著提高6倍左右;而病理切片下观察到肝细胞呈轻度细胞水肿,可见肝细胞点状坏死,肝小叶及汇管区可见炎细胞浸润。因此,建立款冬花中克氏千里光碱的测定方法对其质量和毒性的控制具有重要意义。Gramine is the most important hepatotoxic component in coltsfoot. Mice were injected intraperitoneally with clematine extracted from coltsfoot flower for 7 days, and the serum alanine aminotransferase (GOT), aspartate aminotransferase (GPT) and total bilirubin (TBIL) in the serum biochemical indexes were the same as those in the control group. The ratio was significantly increased by about 6 times; however, mild edema of hepatocytes was observed in pathological sections, punctate necrosis of hepatocytes, and inflammatory cell infiltration in the hepatic lobules and portal areas. Therefore, it is of great significance to establish a method for the determination of senilin in coltsfootia to control its quality and toxicity.
由于款冬花中的克氏千里光碱含量较低(一般低于万分之一),常规的液相色谱法难以直接进行含量测定,现有的研究报道大多采用液质联用技术进行测定,液质联用技术具有极高的灵敏度和较强的结构鉴定能力,是目前测定克氏千里光碱的主要手段,目前有多篇文献报道。例如:乔月等人,2019年在中国实验方剂学杂志发表的“基于UPLC-MS/MS同时测定款冬花中吡咯里西啶生物碱及其氮氧化物的含量”。该作者建立款冬花药材中的UPLC-MS/MS方法,同时测定了15种吡咯里西啶生物碱的含量,从药材中对包括克氏千里光碱在内的5种成分进行了定量研究,定量方法为超高效液相色谱-三重四级杆质谱法。然而,该方法存在以下问题:(1)液质联用仪价格较高,一般需要200万以上,而目前很多药材饮片企业并不具备购买该仪器的能力,因此采用该方法检测,大大增加企业的检测成本和经济负担;(2)测定时,需要使用高纯液氮,质谱级试剂,测试成本远高于超高效液相色谱法、高效液相色谱法等其他测试方法;(3)液质联用仪对实验操作人员的技术要求较高,和超高效液相色谱仪相比,实验人员需要多出数倍的培训时间,方能熟练掌握并操作仪器;(4)对含量测定的准确性和试验精密度来说,液质联用法测定的准确度和试验精密度不如超高效液相色谱法。Due to the low content of clematis in Coltsfoot (generally less than 1/10,000), it is difficult to directly measure the content by conventional liquid chromatography. Most of the existing research reports use LC/MS to measure, Liquid chromatography-mass spectrometry (LC-MS) has extremely high sensitivity and strong structural identification ability, and is currently the main method for the determination of keloids, and there are many reports in the literature. For example: Qiao Yue et al., "Simultaneous determination of pyrrolizidine alkaloids and nitrogen oxides in coltsfoot flowers based on UPLC-MS/MS" published in the Chinese Journal of Experimental Formulary in 2019. The author established a UPLC-MS/MS method in coltsfootia medicinal materials, simultaneously determined the content of 15 pyrrolizidine alkaloids, and carried out quantitative research on 5 components including senilin from the medicinal materials. The quantitative method was ultra-high performance liquid chromatography-triple quadrupole mass spectrometry. However, this method has the following problems: (1) The price of the LC/MS instrument is relatively high, generally requiring more than 2 million yuan. At present, many medicinal herb decoction pieces enterprises do not have the ability to purchase this instrument. Therefore, using this method for detection will greatly increase the number of enterprises. (2) High-purity liquid nitrogen and mass spectrometry-grade reagents are required for the measurement, and the test cost is much higher than other test methods such as ultra-high performance liquid chromatography and high performance liquid chromatography; (3) liquid nitrogen Mass spectrometry has higher technical requirements for experimental operators. Compared with ultra-high performance liquid chromatography, experimenters need several times more training time to master and operate the instrument proficiently; (4) For content determination In terms of accuracy and test precision, the accuracy and test precision of LC-MS assay are not as good as that of ultra-high performance liquid chromatography.
Mroczek等人,2002年在Journal of Chromatography A发表的论文(Simultaneous determination of N-oxides and free bases of pyrrolizidinealkaloids by cation-exchange solid-phase extraction and ion-pair high-performance liquid chromatography),该作者建立阳离子交换固相萃取富集款冬花水提物中的吡咯里西啶生物碱,采用正己烷磺酸作为离子对试剂,建立离子对高效液相色谱法(High Performance Ion Pair Chromatography,HPIPC),采用C8色谱柱,流动相为乙腈-1%磷酸水溶液(含5mM正己烷磺酸钠)梯度洗脱,在220nm波长下检测克氏千里光碱,检测时间大约需要20分钟,定量限约为0.2μg·ml-1。然而,该方法仍存在以下问题:(1)由于采用离子对色谱法,使用正己烷磺酸钠为离子对试剂加到流动相中,在色谱条件下,正己烷磺酸钠和克氏千里光碱形成疏水型的离子对化合物,从而控制克氏千里光碱的保留行为的一种色谱法,该方法的原理是不同于一般的反相HPLC法,比反相HPLC法操作更复杂,而且加入的盐类离子对试剂容易损伤色谱柱寿命。(2)加入的盐类离子对试剂,不仅与待测化合物形成可检测的物质,还会与其他很多成分形成可检测的物质,色谱图上检测到的是化学成分和正己烷磺酸的加合物,其他色谱条件不变的情况下,离子对色谱得到的色谱图比反相HPLC法得到的色谱图往往更复杂,就克氏千里光碱峰来说,色谱峰内疑似包埋有其他色谱峰。(3)该文献中采用梯度洗脱,洗脱过程更复杂,色谱基线更不稳,色谱图不好。Mroczek et al., Journal of Chromatography A, 2002 (Simultaneous determination of N-oxides and free bases of pyrrolizidinealkaloids by cation-exchange solid-phase extraction and ion-pair high-performance liquid chromatography), the authors established cation exchange Solid-phase extraction was used to enrich the pyrrolizidine alkaloids in the water extract of Coltsfoot, using n-hexane sulfonic acid as the ion-pair reagent to establish an ion-pair high performance liquid chromatography (High Performance Ion Pair Chromatography, HPIPC), using C8 chromatography Column, the mobile phase is acetonitrile-1% phosphoric acid aqueous solution (containing 5mM sodium n-hexane sulfonate) gradient elution, at 220nm wavelength to detect kelvin base, the detection time is about 20 minutes, the limit of quantification is about 0.2μg·ml -1. However, this method still has the following problems: (1) due to the use of ion-pair chromatography, sodium n-hexane sulfonate is used as an ion-pair reagent to be added to the mobile phase, and under chromatographic conditions, sodium n-hexane sulfonate and Kelvin A chromatographic method in which the base forms a hydrophobic ion-pair compound, thereby controlling the retention behavior of kelvin base. The principle of this method is different from the general reversed-phase HPLC method. The salt ion-pairing reagents can easily damage the column life. (2) The added salt ion-pair reagent not only forms detectable substances with the compound to be tested, but also forms detectable substances with many other components. What is detected on the chromatogram is the addition of chemical components and n-hexanesulfonic acid. When other chromatographic conditions remain unchanged, the chromatogram obtained by ion-pair chromatography is often more complex than that obtained by reversed-phase HPLC. As for the kelvin base peak, it is suspected that other chromatograms are embedded in the chromatographic peak. chromatographic peaks. (3) Gradient elution is used in this document, the elution process is more complicated, the chromatographic baseline is more unstable, and the chromatogram is not good.
发明内容SUMMARY OF THE INVENTION
为解决上述技术问题,本发明的目在于提供一种款冬花中克氏千里光碱的超高效液相色谱分析方法。该方法是基于反相超高效液相色谱-紫外检测器,无需与质谱连用,并且无需添加离子对试剂,5min内即可完成对克氏千里光碱的检测,灵敏度高(定量限为0.1μg·ml-1),准确性和重现性好,检测成本低。In order to solve the above-mentioned technical problems, the object of the present invention is to provide an ultra-high performance liquid chromatographic analysis method of senilin in Coltsfoot. The method is based on a reversed-phase ultra-high performance liquid chromatography-ultraviolet detector, which does not need to be used in conjunction with mass spectrometry, and does not need to add ion-pairing reagents. ·ml -1 ), good accuracy and reproducibility, and low detection cost.
为实现上述目的,本发明具体是采用如下技术方案实现的:To achieve the above object, the present invention specifically adopts the following technical solutions to realize:
一种款冬花中克氏千里光碱的超高效液相色谱分析方法,包括以下步骤:An ultra-high performance liquid chromatographic analysis method for senilin in coltsfoot, comprising the following steps:
(1)对照品溶液的配制(1) Preparation of reference solution
取克氏千里光碱对照品适量,精密称定,加甲醇制成每1ml含20μg的溶液,备用;Take an appropriate amount of kelvin base reference substance, accurately weigh it, add methanol to make a solution containing 20μg per 1ml, for use;
(2)供试品溶液的制备(2) Preparation of the test solution
取过四号筛的款冬花粉末,精密称定,置具塞锥形瓶中,加甲醇,超声处理,过滤,残渣用甲醇洗涤,过滤,合并滤液,减压回收溶剂,加入0.5%的硫酸水溶液溶解或混悬,进行固相萃取;Take the coltsfoot flower powder that has passed through the No. 4 sieve, accurately weigh it, put it in a stoppered conical flask, add methanol, ultrasonically treat, filter, wash the residue with methanol, filter, combine the filtrates, recover the solvent under reduced pressure, add 0.5% sulfuric acid The aqueous solution is dissolved or suspended, and solid-phase extraction is performed;
所述固相萃取具体流程为:先用甲醇活化阳离子固相萃取柱后,用0.5%硫酸水溶液平衡固相萃取柱,然后将硫酸水的样品溶液加至固相萃取柱上,甲醇淋洗除杂,浓度为8%的氨水-甲醇=1:3溶液洗脱,收集洗脱液,减压回收溶剂,加入甲酸,用水定容,有机滤膜过滤,备用;The specific process of the solid-phase extraction is as follows: after first activating the cationic solid-phase extraction column with methanol, equilibrating the solid-phase extraction column with 0.5% sulfuric acid aqueous solution, then adding the sample solution of sulfuric acid water to the solid-phase extraction column, and rinsing with methanol to remove Mixed, the concentration is 8% ammonia water-methanol=1:3 solution elution, collect the eluate, recover the solvent under reduced pressure, add formic acid, make up to volume with water, filter with organic membrane, and set aside;
(3)色谱条件(3) Chromatographic conditions
流动相为乙腈-0.1%磷酸水溶液=15:85;流速0.3ml/min;色谱柱:UPLC柱,紫外检测器,检测波长220nm;柱温:30℃;进样量:1μl;Mobile phase: acetonitrile-0.1% phosphoric acid aqueous solution=15:85; flow rate 0.3ml/min; chromatographic column: UPLC column, UV detector, detection wavelength 220nm; column temperature: 30℃; injection volume: 1μl;
(4)测定:精密吸取对照品溶液和供试品溶液各1μl,注入超高效液相色谱仪,测定,即得。(4) Determination: Precisely draw 1 μl each of the reference solution and the test solution, inject it into an ultra-high performance liquid chromatograph, and measure.
作为本发明的优选,供试品溶液制备时,超声处理的功率300W,频率40kHz。As a preference of the present invention, when the test solution is prepared, the power of ultrasonic treatment is 300W and the frequency is 40kHz.
作为本发明的优选,所述固相萃取柱的填料为阳离子交换树脂,容量为500mg/6mL。As a preference of the present invention, the filler of the solid phase extraction column is a cation exchange resin, and the capacity is 500 mg/6 mL.
作为本发明的优选,所述UPLC柱的柱长为50mm,内径为2.1mm,粒径为1.7μm。As a preference of the present invention, the column length of the UPLC column is 50 mm, the inner diameter is 2.1 mm, and the particle size is 1.7 μm.
本发明优点和积极效果:Advantages and positive effects of the present invention:
(1)本发明提供的方法无需使用液质联用仪,仅使用超高效液相色谱仪,即可达到较高的灵敏度,定量限为0.1μg·ml-1,重复性、试验精密度和准确性都优于液质联用法,操作也较为简便,而且一台超高效液相色谱仪的成本在50万元左右,远远低于液质联用法,检测时对试剂选择色谱级即可,检测成本也明显低于液质联用法。(1) The method provided by the present invention does not require the use of a liquid chromatography-mass spectrometer, and only uses an ultra-high performance liquid chromatograph to achieve high sensitivity, the limit of quantification is 0.1 μg·ml -1 , and the repeatability, test precision and The accuracy is better than that of LC/MS, and the operation is relatively simple, and the cost of an ultra-high performance liquid chromatograph is about 500,000 yuan, which is far lower than that of LC/MS. The reagents can be selected at the chromatographic grade during detection. , the detection cost is also significantly lower than that of LC/MS.
(2)本发明提供的方法不使用离子对试剂,大大降低对色谱柱的损伤和检测成本。(2) The method provided by the present invention does not use ion pair reagents, which greatly reduces the damage to the chromatographic column and the detection cost.
(3)本发明恒流洗脱,色谱峰形好,保留时间短,色谱基线稳,图谱质量大大优于离子对色谱图,具有精密度好,检测方便、快捷、成本低的优势。(3) The present invention has constant current elution, good chromatographic peak shape, short retention time, stable chromatographic baseline, and the quality of the spectrum is much better than that of the ion-pair chromatogram, and has the advantages of good precision, convenient and fast detection and low cost.
附图说明Description of drawings
图1克氏千里光碱化学结构式;Fig. 1 The chemical structural formula of kelvin base;
图2克氏千里光碱对照品UPLC色谱图;Fig. 2 UPLC chromatogram of senilic acid reference substance;
图3编号为1的款冬花样品UPLC色谱图;Fig. 3 No. 1 UPLC chromatogram of coltsfoot flower sample;
图4克氏千里光碱紫外光谱图;Fig. 4 The ultraviolet spectrum of kelvin base;
图5克氏千里光碱标准曲线图。Figure 5. The standard curve of senilin.
具体实施方式Detailed ways
以下结合附图和具体实施方式对本发明作以进一步的阐述,以便本领域的技术人员更了解本发明,但并不以此限制本发明。The present invention is further described below with reference to the accompanying drawings and specific embodiments, so that those skilled in the art can better understand the present invention, but the present invention is not limited by this.
仪器与试药Instruments and Reagents
仪器:沃特世H-CLASS超高效液相色谱仪,二极管阵列检测器;色谱柱:ACQUITYBEH Shield RP18,2.1×50mm,1.7um;电子天平米特勒XS105DU十万分之一电子天平。Instrument: Waters H-CLASS ultra-high performance liquid chromatograph, diode array detector; chromatographic column: ACQUITYBEH Shield RP18, 2.1×50mm, 1.7um; electronic
试药:克氏千里光碱对照品(德国PhytoLab公司产品);款冬花药材为原产地采集。Reagent: Keshi senilic acid alkali reference substance (product of German PhytoLab company); coltsfoot medicinal material is collected from the place of origin.
实施例1Example 1
款冬花中克氏千里光碱的超高效液相色谱分析方法,包括以下步骤:The ultra-high performance liquid chromatographic analysis method of clematis in coltsfoot, including the following steps:
(1)对照品溶液的配制(1) Preparation of reference solution
取克氏千里光碱对照品适量,精密称定,加甲醇制成每1ml含20μg的溶液,备用;Take an appropriate amount of kelvin base reference substance, accurately weigh it, add methanol to make a solution containing 20μg per 1ml, for use;
(2)含量测定供试品溶液制备(2) Preparation of test solution for content determination
取款冬花粉末(过四号筛)2.00g,精密称定,置具塞锥形瓶中,加甲醇40ml,超声处理(功率300W,频率40kHz)30min,过滤,残渣用5ml甲醇洗涤2次,过滤,合并滤液,50℃减压回收溶剂至约1ml,后加入0.5%的硫酸水溶液10ml溶解或混悬,进行固相萃取;Withdraw 2.00 g of winter flower powder (passed through a No. 4 sieve), accurately weigh it, put it in a stoppered conical flask, add 40 ml of methanol, ultrasonically treat it (power 300 W,
所述固相萃取具体流程为:先用5ml甲醇活化阳离子固相萃取柱(阳离子交换树脂,容量500mg/6mL)后,用0.5%硫酸水溶液平衡固相萃取柱,然后将上述硫酸水的样品溶液加至固相萃取柱上,甲醇20ml淋洗除杂,浓度为8%氨水-甲醇=1:3溶液10ml洗脱,收集洗脱液,50℃减压回收溶剂至约2ml,加入甲酸1ml,用水定容至5ml,0.22μm有机滤膜过滤,备用;The specific process of the solid phase extraction is as follows: first activate a cationic solid phase extraction column (cation exchange resin, capacity 500 mg/6 mL) with 5 ml of methanol, equilibrate the solid phase extraction column with a 0.5% aqueous sulfuric acid solution, and then add the above-mentioned sample solution of sulfuric acid water to the solid phase extraction column. Add it to the solid phase extraction column, rinse with 20 ml of methanol to remove impurities, and elute with 10 ml of 8% ammonia water-methanol=1:3 solution, collect the eluate, recover the solvent under reduced pressure at 50 °C to about 2 ml, add 1 ml of formic acid, Dilute to 5ml with water, filter with 0.22μm organic filter, set aside;
(3)色谱条件(3) Chromatographic conditions
流动相为乙腈-0.1%磷酸水溶液(15:85);流速0.3ml/min;色谱柱:UPLC柱(柱长为50mm,内径为2.1mm,粒径为1.7μm),检测波长:220nm;柱温:30℃;进样量:1μl;Mobile phase is acetonitrile-0.1% phosphoric acid aqueous solution (15:85); flow rate 0.3ml/min; chromatographic column: UPLC column (column length is 50mm, inner diameter is 2.1mm, particle size is 1.7μm), detection wavelength: 220nm; Temperature: 30℃; Injection volume: 1μl;
(4)测定:精密吸取对照品溶液和供试品溶液各1μl,注入超高效液相色谱仪,测定,即得。(4) Determination: Precisely draw 1 μl each of the reference solution and the test solution, inject it into an ultra-high performance liquid chromatograph, and measure.
方法学考察:Methodological investigation:
线性关系:精密吸取对照品储备溶液,加甲醇配制成2.048、5.12、10.24、20.48、40.96、81.82μg·ml-1的对照品系列溶液,进样测定,以对照品浓度x(μg·ml-1)为横坐标,峰面积y为纵坐标绘制标准曲线(见图5),并进行线性回归,得回归方程:Linear relationship: Precisely draw the reference substance stock solution, add methanol to prepare reference substance series solutions of 2.048, 5.12, 10.24, 20.48, 40.96 , 81.82 μg·ml -1 1 ) is the abscissa, and the peak area y is the ordinate to draw a standard curve (see Figure 5), and perform linear regression to obtain the regression equation:
y=34745x–573;r=1.0000y=34745x–573; r=1.0000
结果表明:克氏千里光碱在2.048~81.82μg·ml-1范围内对照品浓度与峰面积呈良好的线性关系。The results showed that the concentration of reference substance had a good linear relationship with the peak area in the range of 2.048~81.82μg·ml -1 .
精密度试验:精密吸取克氏千里光碱对照品溶液1μl,连续进样6次,测定其峰面积,RSD分别为0.63%(n=6),结果见表1,结果表明仪器精密度良好。Precision test: Accurately absorb 1 μl of kelvin base reference solution, inject 6 times continuously, measure the peak area, the RSD is 0.63% (n=6) respectively, the results are shown in Table 1, and the results show that the instrument has good precision.
表1精密度试验结果Table 1 Precision test results
稳定性试验:精密吸取同一供试品溶液(编号1),分别于配制后0、2、4、8、12和24h,按前述色谱条件测定峰面积,克氏千里光碱峰面积平均值为769844,RSD为0.76%,供试品溶液在24h内稳定,结果见表2。Stability test: Precisely draw the same test solution (No. 1), and at 0, 2, 4, 8, 12 and 24 hours after preparation, measure the peak area according to the aforementioned chromatographic conditions. 769844, the RSD is 0.76%, the test solution is stable within 24h, and the results are shown in Table 2.
表2稳定性试验结果Table 2 Stability test results
重复性试验:取本品粉末(编号1),2.00g,共6份,按前述方法测定,结果克氏千里光碱平均含量为0.00534%,RSD为2.44%,表明本试验重复性良好,结果见表3。Repeatability test: Take this product powder (No. 1), 2.00g, a total of 6 parts, and measure it according to the aforementioned method. The result shows that the average content of senilin is 0.00534%, and the RSD is 2.44%, indicating that the test has good repeatability. See Table 3.
表3重复性试验结果Table 3 Repeatability test results
回收率试验:取已知含量的同一批样品(编号1),6份,每份1.00g,分别置具塞锥形瓶中,再分别依次精密加入浓度为40.96μg·mL-1的克氏千里光碱对照品溶液1.0mL,再精密加入甲醇40mL,剩余步骤按照供试品溶液制备方法制备,测定,计算回收率,结果见表4。Recovery test: Take the same batch of samples (No. 1) with known content, 6 parts, 1.00g each, put them in conical flasks with stoppers respectively, and then accurately add Kjeldahl with a concentration of 40.96μg·mL -1 in turn. 1.0 mL of the reference solution of sensible alkali, and then 40 mL of methanol was added precisely, and the remaining steps were prepared according to the preparation method of the test solution, measured, and the recovery rate was calculated. The results are shown in Table 4.
表4回收率试验结果Table 4 Recovery test results
上述结果表明,6份克氏千里光碱的总回收率为89.46%,RSD值为2.80%,该方法准确率高。The above results show that the total recovery rate of 6 parts of phyllostatin is 89.46%, and the RSD value is 2.80%, and the method has high accuracy.
样品含量测定:对收集的各地样品,按上述方法测定,用外标法计算含量,见表5。Determination of sample content: The collected samples were determined according to the above method, and the content was calculated by the external standard method, as shown in Table 5.
表5样品含量测定结果Table 5 Sample Content Determination Results
Claims (4)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010472520.8A CN111537647A (en) | 2020-05-29 | 2020-05-29 | Ultra-high performance liquid chromatography analysis method for crimson-cleft-camaldine in flos farfarae |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010472520.8A CN111537647A (en) | 2020-05-29 | 2020-05-29 | Ultra-high performance liquid chromatography analysis method for crimson-cleft-camaldine in flos farfarae |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111537647A true CN111537647A (en) | 2020-08-14 |
Family
ID=71978036
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010472520.8A Pending CN111537647A (en) | 2020-05-29 | 2020-05-29 | Ultra-high performance liquid chromatography analysis method for crimson-cleft-camaldine in flos farfarae |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111537647A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112924583A (en) * | 2021-01-27 | 2021-06-08 | 中国食品药品检定研究院 | Method for determining pyrrolizidine alkaloid in eupatorium |
| CN112946098A (en) * | 2021-01-19 | 2021-06-11 | 中国农业科学院茶叶研究所 | Method for detecting pyrrolizidine alkaloids in tea and chrysanthemum |
| CN113252830A (en) * | 2021-05-07 | 2021-08-13 | 中国食品药品检定研究院 | Risk assessment method for pyrrolizidine alkaloid in gynura segetum |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108169387A (en) * | 2016-12-07 | 2018-06-15 | 中国科学院大连化学物理研究所 | The liquid of Pyrrolizidine alkaloid/matter analysis Pretreatment Method in a kind of Chinese medicine preparation |
-
2020
- 2020-05-29 CN CN202010472520.8A patent/CN111537647A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108169387A (en) * | 2016-12-07 | 2018-06-15 | 中国科学院大连化学物理研究所 | The liquid of Pyrrolizidine alkaloid/matter analysis Pretreatment Method in a kind of Chinese medicine preparation |
Non-Patent Citations (4)
| Title |
|---|
| LI-HUA CHEN等: "Simultaneous Determination and Risk Assessment of Pyrrolizidine Alkaloids in Artemisia capillaris Thunb.by UPLC-MS/MS Together with Chemometrics", 《MOLECULES》 * |
| 乔月等: "基于UPLC-MS/MS同时测定款冬花中吡咯里西啶生物碱及其氮氧化物的含量", 《中国实验方剂学杂志》 * |
| 吴笛等: "HPLC-ESI-ITMS 法分析蜜炙前后款冬花中毒性成分克氏千里光碱的变化", 《中成药》 * |
| 宁娱等: "HPLC法测定一点红中克氏千里光碱的含量", 《中国药品标准》 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112946098A (en) * | 2021-01-19 | 2021-06-11 | 中国农业科学院茶叶研究所 | Method for detecting pyrrolizidine alkaloids in tea and chrysanthemum |
| CN112924583A (en) * | 2021-01-27 | 2021-06-08 | 中国食品药品检定研究院 | Method for determining pyrrolizidine alkaloid in eupatorium |
| CN112924583B (en) * | 2021-01-27 | 2022-12-06 | 中国食品药品检定研究院 | Method for determining pyrrolizidine alkaloid in eupatorium |
| CN113252830A (en) * | 2021-05-07 | 2021-08-13 | 中国食品药品检定研究院 | Risk assessment method for pyrrolizidine alkaloid in gynura segetum |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107796892B (en) | Fingerprint of Gentiana macrophylla capsule and its application in quality control and component analysis | |
| CN111537647A (en) | Ultra-high performance liquid chromatography analysis method for crimson-cleft-camaldine in flos farfarae | |
| CN103833803B (en) | The method of sweeting agent in ultrasonic extraction and resin purification Pasania cuspidata leaf | |
| Zhang et al. | Simultaneous quantification of 17 constituents from Yuanhu Zhitong tablet using rapid resolution liquid chromatography coupled with a triple quadrupole electrospray tandem mass spectrometry | |
| Luo et al. | Development of UPLC-Q-TOF-MS coupled with cation-exchange solid-phase extraction method for the determination of ten pyrrolizidine alkaloids in herbal medicines | |
| CN114894927B (en) | Method for measuring content of pyrrolizidine alkaloids in gynura divaricata serving as Yao medicine | |
| CN108490083B (en) | Quality detection method of Suhuang cough-relieving capsule | |
| EP2144058A1 (en) | Detection of blood plasma amygdalin of dissipating blood stasis botanical | |
| CN113655135A (en) | A kind of quantitative detection method and limit method of aristolochic acid I | |
| CN103926332A (en) | Ultra performance liquid chromatography method for simultaneously determining contents of uridine, guanosine and adenosine in rhizoma pinelliae extract | |
| CN104569195B (en) | A kind of method of flavonoids effective constituent content in toothpaste detected containing baikal skullcap root | |
| CN115343376A (en) | Method for detecting or separating components of stomach-clearing coptis tablet | |
| CN104133028B (en) | A kind of method for building up of madder granule efficient liquid-phase chromatograph finger print atlas | |
| CN108414667B (en) | Method for detecting quality standard of Shengui Yixin granules | |
| Shi et al. | In-syringe chitosan-assisted dispersive micro-solid phase extraction for the determination of anthraquinones in rhubarb-based oral liquids using high performance liquid chromatography | |
| CN106610406A (en) | Micro-extraction method of honeysuckle | |
| Yu et al. | Simultaneous Determination of Components in Preparation Naodesheng Injection by High Performance Liquid Chromatograph–Atmospheric Pressure Chemical Ionization Mass Spectrometry (HPLC-MS/APCI) | |
| CN114224951A (en) | Industrial preparation method of total alkaloids in Coptis and Evodia composition | |
| CN108061761B (en) | Method for measuring content of alkaloid components in blood-nourishing brain-refreshing alcohol extract | |
| CN112415109A (en) | HPLC (high performance liquid chromatography) detection method for simultaneously determining different characteristic components in acne-removing composition | |
| CN113201037B (en) | Compound and Xian Mao Biaozhun decoction containing same | |
| CN119510609B (en) | Method for simultaneously measuring low-content active chemical components in tetrandra and astragalus decoction | |
| CN106645439B (en) | Detection method of components in rhizoma acori graminei extract | |
| CN114720576B (en) | Method for enriching and purifying steroid alkaloids in fritillaria medicinal materials | |
| CN113956310B (en) | Separation and extraction method of flavonoid carbon glycoside monomer in the aerial part of Clover |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |